Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review

Neurology. 2026 Jul 28;107(2):e218267. doi: 10.1212/WNL.0000000000218267. Epub 2026 Jul 2.ABSTRACTBACKGROUND AND OBJECTIVES: Subarachnoid hemorrhage (SAH) is associated with high mortality and long-term morbidity, as well as a considerable economic burden. Screening for unruptured intracranial aneur

A Andrei Schildt

Metabolic Syndrome and Risk of Atrial Fibrillation in Chronic Kidney Disease

Am J Nephrol. 2026 Jul 2:1-28. doi: 10.1159/000553385. Online ahead of print.ABSTRACTIntroduction Metabolic syndrome is a potent risk factor for adverse cardiovascular outcomes including atrial fibrillation (AF). Although metabolic syndrome is common among patients with chronic kidney disease (CKD),

K Katherine Scovner Ravi

A Comprehensive Review of PCSK9 Inhibitor Therapy

J Cardiovasc Pharmacol. 2026 Jul 2. doi: 10.1097/FJC.0000000000001852. Online ahead of print.ABSTRACTProprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a key component of lipid-lowering therapies for atherosclerotic cardiovascular disease risk management in high-risk primary and se

M Madelyn Hurwitz

The role of the heart-on-a-chip to drug evaluation

Ann Biol Clin (Paris). 2026 Jul 2;84(3):0. doi: 10.1684/abc.2026.2045. Online ahead of print.ABSTRACTOrgans-on-a-Chip (OoC) are innovative models designed to reproduce an architecture close to in vivo physiology, by recreating the specific microenvironment of each organ. They represent a promising a

P Paul Houeto